Kate Baicker | |
---|---|
Provost of the University of Chicago | |
Assumed office March 20, 2023 | |
Preceded by | Ka Yee Lee |
Personal details | |
Born | May 23,1971 |
Education | Yale University (BA) Harvard University (MA,PhD) |
Scientific career | |
Fields | Public administration;Economics |
Thesis | Fiscal federalism and social insurance (1998) |
Katherine Baicker (born May 23,1971) is an American health economist best known for the Oregon Medicaid health experiment. She serves as the provost of the University of Chicago.
Baicker received her B.A. in economics from Yale University in 1993 and her Ph.D. in economics from Harvard University in 1998. She began her academic career teaching economics at Dartmouth College from 1998 to 2005 and her political career in 2001,serving as a senior economist for the President's Council of Economic Advisors. From 2005 to 2007,she taught public policy at the University of California Los Angeles School of Public Affairs. During this period she rejoined the Council of Economic Advisors as a congressionally confirmed chief economist. In 2007 she moved to Harvard University where she held positions in the Kennedy School of Government and the T.H. Chan School of Public Health until 2017 when she accepted the position of dean at the Harris School of Public Policy at the University of Chicago. [1]
She currently serves on the Editorial Boards of Health Affairs,the Journal of Health Economics,and the Forum for Health Economics and Policy;as Vice Chair of the Board of Directors of AcademyHealth;on the Congressional Budget Office's Panel of Health Advisers;and was a Commissioner on the Medicare Payment Advisory Commission. She is a Director at Eli Lilly and Company. [2]
In March 2023,she became the fifteenth Provost of the University of Chicago. [3]
Her research areas include health economics,welfare,and public finance,with a particular focus on the financing of health insurance,spending on public programs,and fiscal federalism.
She believes in Medicare copayments as a way of reducing medical spending on unnecessary care. Copayments should be limited to a maximum patient contribution,to avoid patients having to pay catastrophic expenses that would defeat the purpose of insurance. Medicare clients should not have to buy supplemental insurance to avoid that risk. But copayments should be low for services that are effective at improving health. [4]
Her research has been published in journals such as Health Affairs ,the Journal of Public Economics ,and the Quarterly Journal of Economics ,and has been featured in the New York Times ,the Wall Street Journal , Business Week ,and on National Public Radio. She is currently one of the leaders of a research program investigating the many effects of expanding health insurance coverage in the context of a randomized Medicaid expansion in Oregon.
In the United States,Medicaid is a government program that provides health insurance for adults and children with limited income and resources. The program is partially funded and primarily managed by state governments,which also have wide latitude in determining eligibility and benefits,but the federal government sets baseline standards for state Medicaid programs and provides a significant portion of their funding. States are not required to participate in the program,although all have since 1982.
Mark Barr McClellan is the director of the Robert J Margolis Center for Health Policy and the Margolis Professor of Business,Medicine and Health Policy at Duke University. Formerly,he was a senior fellow and director of the Health Care Innovation and Value Initiative at the Engelberg Center for Health Care Reform at The Brookings Institution,in Washington,D.C. McClellan served as commissioner of the United States Food and Drug Administration under President George W. Bush from 2002 through 2004,and subsequently as administrator of the Centers for Medicare and Medicaid Services from 2004 through 2006.
The RAND Health Insurance Experiment was an experimental study from 1974 to 1982 of health care costs,utilization and outcomes in the United States,which assigned people randomly to different kinds of plans and followed their behavior. Because it was a randomized controlled trial,it provided stronger evidence than the more common observational studies and concluded that cost sharing reduced "inappropriate or unnecessary" medical care (overutilization) but also reduced "appropriate or needed" medical care.
Tomas J. Philipson is a Swedish-born American economist who served as the Acting Chairman of the Council of Economic Advisers in the Trump administration. He departed from the position and the Council at the end of June,2020,to return to the University of Chicago. He holds the Daniel Levin Chair in Public Policy at the University of Chicago,with posts in the Harris School of Public Policy Studies,Department of Economics,and the Law School. He was a Director of the Becker Friedman Institute at the university.
Healthcare rationing in the United States exists in various forms. Access to private health insurance is rationed on price and ability to pay. Those unable to afford a health insurance policy are unable to acquire a private plan except by employer-provided and other job-attached coverage,and insurance companies sometimes pre-screen applicants for pre-existing medical conditions. Applicants with such conditions may be declined cover or pay higher premiums and/or have extra conditions imposed such as a waiting period.
Joseph P. Newhouse is an American economist and the John D. MacArthur Professor of Health Policy and Management at Harvard University,as well as the Director of the Division of Health Policy Research and of the Interfaculty Initiative on Health Policy. At Harvard,he is a member of the four faculties at Harvard Kennedy School in Cambridge,Harvard Medical School in Boston,Harvard T.H. Chan School of Public Health in Boston,and Harvard Faculty of Arts and Sciences in Cambridge.
Amy Nadya Finkelstein is an American economist who is a professor of economics at the Massachusetts Institute of Technology (MIT),the co-director and research associate of the Public Economics Program at the National Bureau of Economic Research,and the co-Scientific Director of J-PAL North America.
Karen Davis is president of The Commonwealth Fund,a national philanthropy engaged in independent research on health and social policy issues. Davis is an economist,with a career in public policy and research. Before joining The Commonwealth Fund,she served as chairman of the Department of Health Policy and Management at The Johns Hopkins School of Public Health,where she also held an appointment as professor of economics. She served as deputy assistant secretary for health policy in the Department of Health and Human Services from 1977–1980,becoming the first woman to head a U.S. public health service agency.
The Oregon health insurance experiment was a research study looking at the effects of the 2008 Medicaid expansion in the U.S. state of Oregon,which occurred based on lottery drawings from a waiting list and thus offered an opportunity to conduct a randomized experiment by comparing a control group of lottery losers to a treatment group of winners,who were eligible to apply for enrollment in the Medicaid expansion program after previously being uninsured.
Value-based insurance design is a demand-side approach to health policy reform. V-BID generally refers to health insurers' efforts to structure enrollee cost-sharing and other health plan design elements to encourage enrollees to consume high-value clinical services –those that have the greatest potential to positively impact enrollee health. V-BID also discourages the use of low-value clinical services –when benefits do not justify the cost. V-BID aims to increase health care quality and decrease costs by using financial incentives to promote cost efficient health care services and consumer choices. V-BID health insurance plans are designed with the tenets of "clinical nuance" in mind. These tenets recognize that medical services differ in the amount of health produced,and the clinical benefit derived from a specific service depends on the consumer using it,as well as when and where the service is provided.
Dorothy P. Rice was an American health statistician whose work contributed to the creation of Medicare in the United States. Rice graduated from the University of Wisconsin–Madison and began working with the US government soon after,but left the workforce to begin raising a child. Just over a decade later,she returned to government work with a position at the Social Security Administration,where she was one of the first scientists to study the economic cost of illness and exposed a lack of health insurance among the elderly.
Ellen Rose Meara is a professor at The Dartmouth Institute for Health Policy and Clinical Practice,part of Dartmouth College in New Hampshire,United States. Her research is in the fields of health economics and health policy. She is also a faculty research fellow at the National Bureau of Economic Research and an adjunct professor in economics at Dartmouth College.
Yuting Zhang is a professor of health economics at the University of Melbourne,and an expert on economic evaluations of health policy and healthcare reforms. She is a journal editor,award recipient,and has written numerous articles in influential journals in her field.
Ilyana Kuziemko is a professor of economics at Princeton University,where she has taught since 2014. She previously served as the David W. Zalaznick Associate Professor of Business at Columbia Business School from July 2013 to June 2014 and as associate professor from July 2012 to June 2013. From 2007 to 2012,she was an assistant professor of economics and public affairs at Princeton University and Woodrow Wilson School. She also served as a Deputy Assistant Secretary for Economic Policy at the U.S. Department of the Treasury from 2009 to 2010 under The Office of Microeconomic Analysis. During her tenure,she worked primarily on the development and early implementation of the Affordable Care Act.
Eric Baird French is the Montague Burton Professor of Industrial Relations and Labour Economics at the University of Cambridge. He is also a Co-Director at the ESRC Centre for the Microeconomic Analysis of Public Policy,a Fellow at the Institute for Fiscal Studies and a Fellow at the Centre for Economic Policy Research. His research interests include:econometrics,labour and health economics.
Melinda Jean Beeuwkes Buntin is an American health economist and a professor at the Johns Hopkins Bloomberg School of Public Health and the Johns Hopkins Carey Business School. Previously,she was the Mike Curb Chair for Health Policy at Vanderbilt University,having served as a deputy assistant director for Health at the Congressional Budget Office.
Oeindrila Dube is an economist and political scientist serving as the Philip K. Pearson Professor of Global Conflict Studies at the University of Chicago,Harris School of Public Policy. She is a faculty research fellow at the National Bureau of Economic Research and co-director of the Crime,Violence,and Conflict Initiative at the Abdul Latif Jameel Poverty Action Lab. Her research examines the political economy of conflict and development,with a regional focus on Africa and Latin America.
Amanda Kowalski is an American health economist serving as the Gail Wilensky Professor of Applied Economics at the University of Michigan. She is an elected member of the executive committee of the American Economic Association,and a research associate at the health,public economics,and aging programs of the National Bureau of Economic Research. Kowalski's research focuses on health policy,in particular on the targeting of treatments and health insurance expansions to those that need them most. She is the winner of the 2019 ASHEcon medal,awarded by the American Society of Health Economists to the best researcher under the age of 40.
Sarah Miller is an American health economist currently serving as associate professor of Business Economics and Public Policy in the University of Michigan Ross School of Business. Her research examines the short and long-term effects of health insurance expansions,and the impacts of income on individuals' health and well-being. In 2022,she received the ASHEcon medal,awarded by the American Society of Health Economists to the best health economist under the age of 40.
Nicole Maestas is an American economist who is the Margaret T. Morris Professor of Health Care Policy at Harvard Medical School and a Research Associate of the National Bureau of Economic Research (NBER),where she directs the NBER's Retirement and Disability Research Center.